The Nuvo start-up is developing Invu, a smart health connected belt to monitoring risky pregnancies

[ad_1]

 "In 2012, my wife was following a high-risk pregnancy. In the past few months, we rushed to the hospital at the slightest signal. If in the end, there was nothing serious, we felt like we were on duty in service with endless expectations. Besides the inconvenience, I could notice a lack of communication between the doctors and very limited means in the data collection. It was there that I had the idea to create Invu ", tells us Oren Oz. Based in Tel Aviv, the founder and CEO of the company Nuvo has long been interested in the well being of babies and pregnant women.

Detecting diseases at risk during pregnancy

In 2007, this engineer, a graduate of Ben Gurion University and a former member of the IDF air force, created clothes for pregnant women who played musical sounds to the fetus. In 2013, with Invu, he created a fetal monitoring system using an electrocardiograph and acoustic sensors placed on a belt. The data collected is transmitted to a cloud service which analyzes it using machine learning. The beta data have already been normalized, digested and would allow reports to be made directly transmitted to the gynecologist and the doctor treating the expectant mother. Invu ensures that the data collected will be anonymous and protected.

 "In the future cases of pre-eclampsia (arterial hypertension) or arrhythmia (heart rhythm problem) could be reported thanks to our sensors. We are working on the prevention of these two phenomena because they can be very problematic for the 'child and mom', says the CEO of Nuvo.

Holistic monitoring

 "My idea was to have a holistic approach to monitoring by collecting both fetal movement, fetal heart rate, maternal heart rate and uterine activity, using surface electrodes." The aim is not only to avoid going to the clinic every week, but also to reduce infant mortality in developed countries like the United States (almost 6 per thousand), twice as much as in Germany. On the strength of this observation, Nuvo decided to set up in Princeton in New Jersey and to validate its thirty or so patents with the American authorities. "The process is underway and should soon be completed", precise, confident, Oren Oz.

Nuvo has already signed a strategic agreement with a leading German healthcare system for future clinical implementation and new research. The start-up has also started discussions in France. "We have a B2B approach, we mainly address the public sector, mutuals or insurance. In France or Germany, the insured would be reimbursed. In the United States, it's a little different: the full service could cost to the patient between a few hundred dollars and over 1000 dollars. Which is always cheaper than a day in hospital with several tests that can cost thousands of dollars. " Ultimately, the interest would also be to allow the hospital sector to save time and save money, by targeting the risks and by triggering alerts only in useful cases.

[ad_2]